← Back to Search
Apolipoprotein E And Cognitive Performance: A Meta-analysis.
B. Small, Christopher B. Rosnick, L. Fratiglioni, L. Bäckman
Published 2004 · Psychology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The epsilon4 allele of the apolipoprotein E (APOE) gene is a known risk factor for Alzheimer's disease and may also affect cognitive performance in normal aging. Evidence of the presence and magnitude of epsilon4-related cognitive deficits was examined with a meta-analysis of the available literature. Thirty-eight studies were included, and cognitive performance was collapsed into 8 domains. Results indicated significant APOE-epsilon4 group differences for global cognitive functioning, episodic memory, and executive functioning, in favor of non-epsilon4 carriers. In addition, older age and APOE-epsilon4 heterozygosity was associated with smaller epsilon4-related impairments. The meta-analysis results suggest that APOE-epsilon4 genotype does affect cognitive performance in healthy aging, although the influence is relatively small and specific to certain domains of cognitive performance.
This paper references
Medical Subject Headings
F. Rogers (1965)
Statistical Power Analysis for the Behavioral Sciences
Jacob Cohen (1969)
Mechanisms of memory.
L. Squire (1986)
Apolipoprotein E Polymorphism and Coronary Artery Disease
H. Menzel (1983)
Statistical Methods for Meta-Analysis
L. Hedges (1987)
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
R. Mahley (1988)
The Journal of Neuropsychiatry and Clinical Neurosciences
V. M. Bowden (1992)
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
W. Strittmatter (1993)
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
R. Reitan (1993)
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E. Corder (1993)
Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults
M. Bondi (1995)
Neuropsychological assessment, 3rd ed.
M. Lezak (1995)
Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes
M. Lehtovirta (1995)
The association of apolipoprotein E polymorphism with memory: a population based study
E. Helkala (1995)
Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates
H. Schmidt (1996)
Activation of medial temporal structures during episodic memory retrieval
L. Nyberg (1996)
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
J. Growdon (1996)
Early effect of ApoE-ϵ4 allele on cognitive results in a group of highly performing subjects: the EVA study
C. Berr (1996)
Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease
M. Lehtovirta (1996)
Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition.
E. Corder (1996)
Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study
E.-L. Helkala (1996)
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
L. Farrer (1997)
Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ϵ4 allele
H. Tohgi (1997)
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis
L. Farrer (1997)
Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition
B. L. Plassman (1997)
Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center.
B. Tardiff (1997)
Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women.
K. Yaffe (1997)
The APOE ∍4 allele Is Associated with Decline on Delayed Recall Performance in Community‐Dwelling Older Adults
R. O'Hara (1998)
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease
C. Jack (1998)
Major decrease in the volume of the entorhinal cortex in patients with Alzheimer’s disease carrying the apolipoprotein E ε4 allele
K. Juottonen (1998)
Longitudinal SPECT study in Alzheimer’s disease: relation to apolipoprotein E polymorphism
Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia.
B. Small (1998)
Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects
G. Smith (1998)
The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons
M. Haan (1999)
APOE-ε4 count predicts age when prevalence of AD increases, then declines
J.C. S. Breitner (1999)
Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
M. Bondi (1999)
Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes
R. Caselli (1999)
The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models
K. Horsburgh (2000)
A Compendium of Neuropsychological Tests, 2nd ed
J. Nici (2000)
Estimation of apolipoprotein E genotype‐specific relative mortality risks from the distribution of genotypes in centenarians and middle‐aged men: Apolipoprotein E gene is a “frailty gene,” not a “longevity gene”
L. Gerdes (2000)
Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults.
J. Flory (2000)
Patterns of brain activation in people at risk for Alzheimer's disease.
S. Bookheimer (2000)
Talkativeness in Cognitively Normal Women at Genetic Risk for Alzheimer’s Disease
M. Newman (2000)
APOE-ε4 is associated with memory decline in cognitively impaired elderly
M. Dik (2000)
Is APOE-ε4 a risk factor for cognitive impairment in normal aging?
B. Small (2000)
Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype
S.D. Moffat (2000)
Education, Activity, Health, Blood Pressure and Apolipoprotein E as Predictors of Cognitive Change in Old Age: A Review
K. Anstey (2000)
Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study.
K. P. Riley (2000)
Apolipoprotein E, Cognitive Function, and Dementia in a General Population Aged 85 Years and Over
K. Juva (2000)
Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study
R. J. Caselli (2001)
Does Apolipoprotein E Influence Learning and Memory in the Nondemented Oldest Old?
A. Salo (2001)
No association between apolipoprotein E polymorphisms and general cognitive ability in children
D. Turic (2001)
Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women
R. Cohen (2001)
Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease
M. Hashimoto (2001)
A gender difference in the association between APOE genotype and age-related cognitive decline
E. L. Mortensen (2001)
Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample
E‐L. Helkala (2001)
Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults
N. Pendleton (2002)
Change in cognitive functioning associated with apoE genotype in a community sample of older adults.
S. Hofer (2002)
The apolipoprotein E gene, attention, and brain function.
R. Parasuraman (2002)
Working memory and apolipoprotein E: What’s the connection?
V. Rosen (2002)
Ageing: Cognitive change and the APOE ɛ4 allele
I. Deary (2002)
A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
R. Caselli (2002)
Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population
A. Yip (2002)
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.
R. Wilson (2002)
Apolipoprotein E ε4 allele is not associated with the cognitive impairment in community‐dwelling normal elderly individuals
Ki Woong Kim (2002)
Apolipoproteins and aging: emerging mechanisms
J. Smith (2002)
The apolipoprotein E ε2 allele and decline in episodic memory
Robert S. Wilson (2002)
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes
T. den Heijer (2002)
Learning and recall in subjects at genetic risk for Alzheimer's disease.
J. Chen (2002)
Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study
M. Winnock (2002)
APOE Genotype, Memory Test Performance, and the Risk of Alzheimer’s Disease in the Canadian Study of Health and Aging
Jennifer D. Klages (2002)
The influence of the e4 allele of the apolipoprotein E gene on childhood IQ, nonverbal reasoning in old age, and lifetime cognitive change
I. Deary (2003)
The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy
T. Ahles (2003)
The role of APOE-&egr;4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging
P. Bretsky (2003)
Context-specific memory and apolipoprotein E (ApoE) ε4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease
J. A. Levy (2004)
Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932.
I. Deary (2004)
This paper is referenced by
Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory
Kirsty Lu (2021)
Associations between race, APOE genotype, cognition, and mortality among urban middle-aged white and African American adults
Jordan Weiss (2021)
Superior short-term memory in APOE ε2 carriers across the age range
N. Zokaei (2020)
Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
G. Piccioni (2021)
Apolipoprotein E ɛ4-related effects on cognition are limited to the Alzheimer's disease spectrum.
Alberto Fernández (2021)
Relationship between a novel learning slope metric and Alzheimer's disease biomarkers.
D. Hammers (2021)
Apolipoprotein E ε4 Allele-Based Differences in Brain Volumes Are Largely Uniform Across Late Middle Aged and Older Hispanic/Latino- and Non-Hispanic/Latino Whites Without Dementia
A. Stickel (2021)
Apolipoprotein E (APOE) ε4 moderates the relationship between c-reactive protein, cognitive functioning, and white matter integrity
Thomas Wooten (2021)
ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study
Farshid Mashayekhi (2021)
Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
Megan A. Iida (2021)
Low CD4 nadir exacerbates the impacts of APOE ε4 on functional connectivity and memory in adults with HIV.
F. Yang (2021)
The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
Emma Rhodes (2021)
Apolipoprotein E Genetic Variation and Its Association With Cognitive Function in Rural-Dwelling Older South Africans
C. Soo (2021)
The role of genetic polymorphisms in executive functioning performance in temporal lobe epilepsy
C. Doherty (2021)
Vascular mild cognitive impairment and its relationship to hemoglobin A1c levels and apolipoprotein E genotypes in the Dominican Republic
M. Medrano (2021)
Quantitative endophenotypes as an alternative approach to understanding genetic risk in neurodegenerative diseases
F. Farias (2021)
Education Moderates the Negative Effect of Apolipoprotein E ɛ4 on Response Inhibition in Older Adults.
Yu-Ling Chang (2021)
Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.
Kathleen H. Elverman (2021)
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe.
M. Boccardi (2021)
A Multivariate Assessment of Age-Related Cognitive Impairment in Octodon degus
Daniela S. Rivera (2021)
Association Between Episodic Memory and Genetic Risk Factors for Alzheimer's Disease in South Asians from the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD).
Jennifer A. Smith (2020)
Editorial: Pathophysiologic Insights From Biomarker Studies in Neurological Disorders
S. Bittner (2020)
Verbal memory dysfunction is associated with alterations in brain transcriptome in dominant temporal lobe epilepsy
R. Busch (2020)
The associations of the BDNF and APOE polymorphisms, hippocampal subfield volumes, and episodic memory performance across the lifespan
N. Malykhin (2020)
Apolipoprotein E ε4 and cognitive function after surgery in middle-aged and elderly Danish twins
U. Dokkedal (2020)
When Culture Influences Genes: Positive Age Beliefs Amplify the Cognitive-Aging Benefit of APOE ϵ2.
B. Levy (2020)
Apolipoprotein ɛ4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics.
D. C. Oviedo (2020)
APOE ε4 and the influence of sex, age, vascular risk factors, and ethnicity on cognitive decline.
S. Makkar (2020)
Predictors of Heterogeneity in Cognitive Function: APOE-e4, Sex, Education, Depression, and Vascular Risk.
R. MacAulay (2020)
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression
Wen Li (2020)
APOE4 affects basal and NMDAR mediated protein synthesis in neurons by perturbing calcium homeostasis
Sarayu Ramakrishna (2020)
Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study.
B. Klinedinst (2020)See more